Sageworth Trust’s Amedisys AMED Stock Holding History

Sageworth Trust’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27	Closed	-$1.99K	–	91
2023 Q1	$1.99K	Hold	27	–	–	﹤0.01%	449
2022 Q4	$2K	Hold	27	–	–	﹤0.01%	328
2022 Q3	$3K	Hold	27	–	–	﹤0.01%	281
2022 Q2	$3K	Hold	27	–	–	﹤0.01%	314
2022 Q1	$5K	Sell	27 -150	-85%	-$22.4K	﹤0.01%	240
2021 Q4	$29K	Sell	177 -594	-77%	-$95.5K	﹤0.01%	143
2021 Q3	$115K	Hold	771	–	–	0.01%	111
2021 Q2	$189K	Buy	771 +120	+18%	+$31.5K	0.01%	117
2021 Q1	$172K	Buy	+651	New	+$184K	0.01%	91

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Sageworth Trust's AMED Position: Q2 2023 in Review

Sageworth Trust sold out of Amedisys (AMED) in Q2 2023, closing a stake of 27 shares — an estimated $1.99K sold.

Sageworth Trust first reported a position in AMED in Q1 2021 and held it in 9 quarters. The position peaked at $189K in Q2 2021. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

Sageworth Trust reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
Sageworth Trust sold 27 Amedisys shares in Q2 2023, an estimated $1.99K.
Sageworth Trust first reported a position in Amedisys in Q1 2021 and held it in 9 quarters.
Sageworth Trust's Amedisys position peaked at $189K in Q2 2021.
301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.